London stocks fell sharply on Wednesday, with investors reacting to heightened geopolitical tensions after China unveiled ...

He says the S&P 500 edged "increasingly close to bear market territory," having shed 18.9% since its peak in mid-February and ...

GSK PLC closed 26.98% short of its 52-week high of £18.24, which the company reached on May 16th.

European stocks ended sharply lower on Wednesday, turning weak once again after having snapped a four-session losing streak on Tuesday. The mood turned bearish ...

Top forecasters on Wall Street are eying the risk of a recession, a global slowdown, and further stock drops ahead.

Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...

Learn more about whether Alvotech or Ionis Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Find insight on Sartorius, China’s healthcare industry and more in the latest Market Talks covering health care.

It has collaboration and license agreement with GlaxoSmithKline to develop and commercialize ... As of April 2, 2025, Amicus ...

Wave Life Sciences Ltd. shares promising updates on AATD & DMD treatments. Click here for my updated look at WVE stock ...

The global Duchenne muscular dystrophy (DMD) market is valued approximately at USD 1.38 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 4.7% over the forecast period ...

The Food and Drug Administration (FDA) has approved a new drug, Blujepa, the first of a new class of oral antibiotics for ...